Display options
Cite
Hyeon J, Ahn S, Lee JJ, et al. Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma. Korean J Pathol. 2013;47(2):130-6doi: 10.4132/KoreanJPathol.2013.47.2.130.
Hyeon, J., Ahn, S., Lee, J. J., Song, D. H., & Park, C. K. (2013). Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma. Korean journal of pathology, 47(2), 130-6. https://doi.org/10.4132/KoreanJPathol.2013.47.2.130
Hyeon, Jiyeon, et al. "Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma." Korean journal of pathology vol. 47,2 (2013): 130-6. doi: https://doi.org/10.4132/KoreanJPathol.2013.47.2.130
Hyeon J, Ahn S, Lee JJ, Song DH, Park CK. Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma. Korean J Pathol. 2013 Apr;47(2):130-6. doi: 10.4132/KoreanJPathol.2013.47.2.130. Epub 2013 Apr 24. PMID: 23667372; PMCID: PMC3647125.
Copy Download .nbib Format: NLM
Share it on

Korean J Pathol. 2013 Apr;47(2):130-6. doi: 10.4132/KoreanJPathol.2013.47.2.130. Epub 2013 Apr 24.

Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.

Korean journal of pathology

Jiyeon Hyeon, Soomin Ahn, Jae Jun Lee, Dae Hyun Song, Cheol-Keun Park

Affiliations

  1. Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

PMID: 23667372 PMCID: PMC3647125 DOI: 10.4132/KoreanJPathol.2013.47.2.130

Abstract

BACKGROUND: BCL9 enhances β-catenin-mediated transcriptional activity regardless of the mutational status of the Wnt signaling components and increases the cell proliferation, migration, invasion, and metastatic potential of tumor cells. The goal of this study was to elucidate the prognostic significance of BCL9 protein expression in hepatocellular carcinoma (HCC) patients.

METHODS: We evaluated BCL9 protein expression by immunohistochemistry in tumor tissue from 288 primary HCC patients who underwent curative hepatectomy. The impact of BCL9 expression on the survival of the patients was analyzed. The median follow-up period was 97.1 months.

RESULTS: Nuclear BCL9 protein expression was observed in 74 (25.7%) of the 288 HCCs. BCL9 expression was significantly associated with younger age (p=0.038), higher Edmondson grade (p=0.001), microvascular invasion (p=0.013), and intrahepatic metastasis (p=0.017). Based on univariate analyses, BCL9 expression showed an unfavorable influence on both disease-free survival (DFS, p=0.012) and disease-specific survival (DSS, p=0.032). Multivariate analyses revealed that higher Barcelona Clinic Liver Cancer stage was an independent predictor of both shorter DFS (p<0.001) and shorter DSS (p<0.001). BCL9 expression tended to be an independent predictor of shorter DFS (p=0.078).

CONCLUSIONS: BCL9 protein expression might be a marker of shorter DFS in HCC patients after curative hepatectomy.

Keywords: BCL9; Carcinoma, hepatocellular; Recurrence; Survival

References

  1. Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):51-9 - PubMed
  2. Semin Liver Dis. 2005;25(2):181-200 - PubMed
  3. Cancer Res. 2009 Oct 1;69(19):7577-86 - PubMed
  4. Gastroenterology. 2011 Oct;141(4):1359-70, 1370.e1-3 - PubMed
  5. Hepatology. 1995 Sep;22(3):983-93 - PubMed
  6. Science. 1997 Mar 21;275(5307):1787-90 - PubMed
  7. Cell. 2002 Apr 5;109(1):47-60 - PubMed
  8. J Cancer Res Clin Oncol. 2004 Sep;130(9):497-513 - PubMed
  9. Int J Cancer. 2008 Dec 15;123(12):2808-15 - PubMed
  10. Genes Dev. 2000 Aug 1;14(15):1837-51 - PubMed
  11. Am J Pathol. 1999 Jan;154(1):37-43 - PubMed
  12. Blood. 1998 Mar 15;91(6):1873-81 - PubMed
  13. Jpn J Surg. 1989 Jan;19(1):98-129 - PubMed
  14. Br J Cancer. 2005 Mar 14;92(5):935-41 - PubMed
  15. Semin Liver Dis. 1999;19(3):329-38 - PubMed
  16. Cancer. 1954 May;7(3):462-503 - PubMed
  17. N Engl J Med. 2008 Nov 6;359(19):1995-2004 - PubMed
  18. Hepatology. 2011 Sep 2;54(3):757-9 - PubMed

Publication Types